Marken announced today the launch of their new website. The site has been completely re-worked to include newly launched services and several new office and depot locations. The site also reflects a new face of the organization.
The website provides visitors with direct links to Marken's state-of-the-art software tracking tools as well as access to Marken's industry experts. All of Marken's 43 locations and 10 GMP-compliant depots can be easily accessed and visualized, providing clients an inside peek into their global infrastructure as more and more clients choose to work with the market leader.
Wes Wheeler, Chief Executive Officer, commented on the organization's growth, "Since 2011, Marken has doubled our global footprint with 65% growth in staff. Two-thirds of our branch offices have been replaced or expanded during this period. With our continuous investment in new services and technology, Marken's 2016 focus will be to provide clients with continued excellent logistics services but reinforced to include, when appropriate, risk assessment and lane verification to meet the new European regulations. We are also building a leading position in direct to patient services, depot-related services and drug development logistics services which are based on gene and cell technologies."
Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient services and biological sample shipments, and offers a state of the art GMP-compliant depot network and logistic hubs in 43 locations worldwide. Marken's 630 staff members manage 50,000 drug and biological shipments every month at all temperature ranges in more than 150 countries. Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken's unique position in the pharma and logistics industry.